Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer
The global increase in cancer mortality and economic losses necessitates the cautious quest for therapeutic agents with compensatory advantages over conventional therapies. Anticancer peptides (ACPs) are a subset of host defense peptides, also known as antimicrobial peptides, which have emerged as t...
Main Authors: | Olalekan Olanrewaju Bakare, Arun Gokul, Ruomou Wu, Lee-Ann Niekerk, Ashwil Klein, Marshall Keyster |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/8/1120 |
Similar Items
-
CancerGram: An Effective Classifier for Differentiating Anticancer from Antimicrobial Peptides
by: Michał Burdukiewicz, et al.
Published: (2020-10-01) -
MDA-MB-231 Breast Cancer Cells Resistant to Pleurocidin-Family Lytic Peptides Are Chemosensitive and Exhibit Reduced Tumor-Forming Capacity
by: Ashley L. Hilchie, et al.
Published: (2020-08-01) -
Analytical Studies of Antimicrobial Peptides as Diagnostic Biomarkers for the Detection of Bacterial and Viral Pneumonia
by: Olalekan Olanrewaju Bakare, et al.
Published: (2022-07-01) -
PR-1-Like Protein as a Potential Target for the Identification of <i>Fusarium oxysporum</i>: An In Silico Approach
by: Olalekan Olanrewaju Bakare, et al.
Published: (2021-04-01) -
An Overview of Antimicrobial Peptides as Anticancer Agents
by: Ali Ganji, et al.
Published: (2019-09-01)